Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 316,889 | 458,480 | 283,255 | 118,095 | 444,091 |
| Depreciation Amortization | 92,261 | 63,727 | 41,806 | 20,586 | 77,744 |
| Income taxes - deferred | 634 | 17,402 | -9,952 | -2,858 | 532 |
| Accounts receivable | -128,063 | -37,580 | -7,884 | 3,834 | -74,245 |
| Other Working Capital | -152,256 | -142,827 | -84,547 | 7,472 | -89,277 |
| Other Operating Activity | 522,093 | 73,327 | 31,254 | 7,092 | 120,219 |
| Operating Cash Flow | $651,558 | $432,529 | $253,932 | $154,221 | $479,064 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 474,893 | -247,355 | -3,121 | -89,472 | -252,027 |
| PPE Investments | -6,970 | 443,330 | -2,513 | -950 | -10,696 |
| Net Acquisitions | -1,013,736 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-545,813 | $195,975 | $-5,634 | $-90,422 | $-262,723 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,470,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -1,229,693 | N/A | N/A | -3,321 | N/A |
| Common Stock Issued | 21,829 | 17,683 | -302,287 | N/A | 31,139 |
| Common Stock Repurchased | -342,372 | -342,372 | N/A | N/A | -250,000 |
| Other Financing Activity | -4,938 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-85,174 | $-324,689 | $-302,287 | $-3,321 | $-218,861 |
| Beginning Cash Position | 115,850 | 115,850 | 115,850 | 115,850 | 118,370 |
| End Cash Position | 136,421 | 419,665 | 61,861 | 176,328 | 115,850 |
| Net Cash Flow | $20,571 | $303,815 | $-53,989 | $60,478 | $-2,520 |
| Free Cash Flow | |||||
| Operating Cash Flow | 651,558 | 432,529 | 253,932 | 154,221 | 479,064 |
| Capital Expenditure | -6,970 | -5,543 | -2,513 | -950 | -10,696 |
| Free Cash Flow | 644,588 | 426,986 | 251,419 | 153,271 | 468,368 |